The tariff classification of Ibuprofen Tablets, Propranolol Tablets, Allopurinol Tablets and Atenolol Tablets from India
Issued February 12, 2007 by U.S. Customs and Border Protection.
Tariff classification
HTS codes: 3004.90.9120, 3004.90.9190, 3004.90.9128
Headings: 3004
Product description
The first product, Ibuprofen Tablets, is a medicinal preparation, in tablet form, containing Ibuprofen, a nonsteroidal anti-inflammatory drug (NSAID), as the active ingredient. The second product, Propranolol Tablets, is a medicinal preparation, in tablet form, containing Propranolol, a drug indicated for the management of hypertension and angina pectoris (among other things), as the active ingredient. The third product, Allopurinol Tablets, is a medicinal preparation, in tablet form, containing Allopurinol, a drug indicated for the treatment of gout, as the active ingredient. The fourth product, Atenolol Tablets, is a medicinal preparation, in tablet form, containing Atenolol, a drug indicated for the treatment of hypertension and angina pectoris, as the active ingredient.
CBP rationale
The applicable subheading for Ibuprofen Tablets will be 3004.90.9128, Harmonized Tariff Schedule of the United States (HTSUS), which provides for “Medicaments … consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses … or in forms or packings for retail sale: Other: Other: Other: Medicaments primarily affecting the central nervous system: Analgesics, antipyretics and nonhormonal anti-inflammatory agents: Other. The applicable subheading for Propranolol Tablets and Atenolol Tablets will be 3004.90.9120, HTSUS, which provides for “Medicaments … consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses … or in forms or packings for retail sale: Other: Other: Other: Cardiovascular medicaments. The applicable subheading for Allopurinol Tablets will be 3004.90.9190, HTSUS, which provides for “Medicaments … consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses … or in forms or packings for retail sale: Other: Other: Other: Other.
Full text
N006187 February 12, 2007 CLA-2-30:RR:E:NC:2:238 CATEGORY: Classification TARIFF NO.: 3004.90.9128; 3004.90.9120; 3004.90.9190 Mr. Colm Moynihan NorthStar Healthcare Limited 3300 Cork Airport Business Park Cork, Ireland RE: The tariff classification of Ibuprofen Tablets, Propranolol Tablets, Allopurinol Tablets and Atenolol Tablets from India Dear Mr. Moynihan: In your letter dated January 31, 2007, you requested a tariff classification ruling. The first product, Ibuprofen Tablets, is a medicinal preparation, in tablet form, containing Ibuprofen, a nonsteroidal anti-inflammatory drug (NSAID), as the active ingredient. The second product, Propranolol Tablets, is a medicinal preparation, in tablet form, containing Propranolol, a drug indicated for the management of hypertension and angina pectoris (among other things), as the active ingredient. The third product, Allopurinol Tablets, is a medicinal preparation, in tablet form, containing Allopurinol, a drug indicated for the treatment of gout, as the active ingredient. The fourth product, Atenolol Tablets, is a medicinal preparation, in tablet form, containing Atenolol, a drug indicated for the treatment of hypertension and angina pectoris, as the active ingredient. The applicable subheading for Ibuprofen Tablets will be 3004.90.9128, Harmonized Tariff Schedule of the United States (HTSUS), which provides for “Medicaments … consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses … or in forms or packings for retail sale: Other: Other: Other: Medicaments primarily affecting the central nervous system: Analgesics, antipyretics and nonhormonal anti-inflammatory agents: Other.” The rate of duty will be free.. The applicable subheading for Propranolol Tablets and Atenolol Tablets will be 3004.90.9120, HTSUS, which provides for “Medicaments … consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses … or in forms or packings for retail sale: Other: Other: Other: Cardiovascular medicaments. The rate of duty will be free. The applicable subheading for Allopurinol Tablets will be 3004.90.9190, HTSUS, which provides for “Medicaments … consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses … or in forms or packings for retail sale: Other: Other: Other: Other.” The rate of duty will be free. Duty rates are provided for your convenience and are subject to change. The text of the most recent HTSUS and the accompanying duty rates are provided on World Wide Web at http://www.usitc.gov/tata/hts/. This merchandise may be subject to the Federal Food, Drug, and Cosmetic Act and/or The Public Health Security and Bioterrorism Preparedness and Response Act of 2002 (The Bioterrorism Act), which are administered by the U.S. Food and Drug Administration (FDA). Information on the Federal Food, Drug, and Cosmetic Act, as well as The Bioterrorism Act, can be obtained by calling the FDA at 1-888-463-6332, or by visiting their website at www.fda.gov. This ruling is being issued under the provisions of Part 177 of the Customs Regulations (19 C.F.R. 177). A copy of the ruling or the control number indicated above should be provided with the entry documents filed at the time this merchandise is imported. If you have any questions regarding the ruling, contact National Import Specialist Harvey Kuperstein at 646-733-3033. Sincerely, Robert B. Swierupski Director, National Commodity Specialist Division
More rulings on the same tariff codes
The tariff classification of Metformin Hydrochloride Extended Release Tablets in dosage form, from India
The tariff classification of Sodium Phenylacetate and Sodium Benzoate injection vials in dosage form, from India
The tariff classification, country of origin and country of origin marking of the AUGMENT® Bone Graft Kit from the United Kingdom and the applicability of subheading 9801.00.10, HTSUS
The tariff classification of GRASTEK® and RAGWITEK® sublingual tablets in dosage form, from Denmark
The tariff classification of Olmesartan Medoxomil Tablets and Spironolactone Tablets in dosage form, from India and China, respectively
The tariff classification of Etodolac ER Tablets in dosage form, from Israel
The tariff classification of Glyburide Tablets and Glyburide-Metformin Hydrochloride Tablets in dosage form, from India
The tariff classification of Voriconazole Tablets and Nateglinide Tablets in dosage form, from Malta and India, respectively
The tariff classification of Bosentan Tablets in dosage form, from India
The tariff classification of Zolderonic Acid Injection in dosage form, from India
Searching CBP rulings the smart way
TariffLens semantically searches all 200,000+ CBP rulings, surfaces the ones that actually match your product, and builds defensible classifications backed by ruling citations.
Book a demo →